Mutant KRAS G12V-specific TCR-transduced T cells

KRAS G12V-specific T cell receptor-transduced T cells · Changhai Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mutant KRAS G12V-specific TCR-transduced T cells, covering 2025-12-24 to 2025-12-24. Get the full timeline:

Most recent: Clinical Trial Update: Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer [Phase 1, Phase 2]